Literature DB >> 35734318

COVID-19 complicated by infective endocarditis or concomitant infection? a case report.

Chaymae Miri1, Falmata Laouan Brem1, Hammam Rasras1, Noha El Ouafi1,2, Bazid Zakaria1,2.   

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic and public health emergency. With a high infectivity and dissemination rate, cardiovascular complications have been observed and associated with a poorer prognosis. COVID-19 appears to be both a risk and prognosis factor for infective endocarditis. In this report, we present the case of a 53-year-old woman with a non-productive cough, progressive dyspnea and fatigue, diagnosed with COVID-19 four weeks earlier. The patient was referred to our department displaying the same symptoms. She was diagnosed with infective endocarditis of the mitral valve based on clinical symptoms, as well as radiological and analytical investigations. The patient was given appropriate medical treatment before admission based on azithromycin, corticosteroids for two weeks, during the hospitalization, she underwent treatment with antibiotics based on Teicoplanin and gentamicin. Outcome was good; the disappearance of the vegetative lesion on the weekly transthoracic echocardiogram (TTE). This rare case highlights questions about considering other coexisting diagnoses as well as possible complications a long with COVID-19. Copyright: Chaymae Miri et al.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; case report; complication; infective endocarditis

Mesh:

Year:  2022        PMID: 35734318      PMCID: PMC9187982          DOI: 10.11604/pamj.2022.41.263.29438

Source DB:  PubMed          Journal:  Pan Afr Med J


  7 in total

1.  Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis.

Authors:  John K McCormick; Timothy J Tripp; Gary M Dunny; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2002-03-11       Impact factor: 5.226

Review 2.  COVID-19 concomitant with infective endocarditis: A case report and review of management.

Authors:  Muzakkir Amir; Irawaty Djaharuddin; Albert Sudharsono; Sri Ramadany
Journal:  Int J Infect Dis       Date:  2020-06-20       Impact factor: 3.623

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

Review 5.  Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Clin Pharmacol Ther       Date:  2020-05-10       Impact factor: 6.903

Review 6.  Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.

Authors:  Elissa Driggin; Mahesh V Madhavan; Behnood Bikdeli; Taylor Chuich; Justin Laracy; Giuseppe Biondi-Zoccai; Tyler S Brown; Caroline Der Nigoghossian; David A Zidar; Jennifer Haythe; Daniel Brodie; Joshua A Beckman; Ajay J Kirtane; Gregg W Stone; Harlan M Krumholz; Sahil A Parikh
Journal:  J Am Coll Cardiol       Date:  2020-03-19       Impact factor: 24.094

7.  Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection.

Authors:  Azin Alizadehasl; Pegah Salehi; Soudeh Roudbari; Mohammad Mehdi Peighambari
Journal:  Eur Heart J       Date:  2020-12-21       Impact factor: 29.983

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.